AHR and renal cell carcinoma: AHR ligands, indirubin or 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), activate the AHR pathway, upregulated the expression of AHR and CYPs, and promoted the renal cell carcinoma invasion by upregulating MMPs [11].